StockData
Korro Bio, Inc. logo

Korro Bio, Inc. (KRRO) income statement

KRRONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$12.18−0.01 (-0.08%)

Close on Nov 20, 2026Market cap $179.36MP/E –Yield –

See a number that looks wrong?